Naturally occurring drug resitance substitutions in the NS5A and NS5B regions in Hepatitis C virus genotype 2 and response to sofosbuvir plus ribavirin therapy

被引：0
|
作者：
Hayashi, K. [1 ]
Ishigami, M. [1 ]
Ishizu, Y. [1 ]
Kazuya, T. [1 ]
Honda, T. [1 ]
Hirooka, Y. [1 ]
Goto, H. [1 ]
机构：
[1] Nagoya Univ, Gastroenterol & Hepatol, Nagoya, Aichi, Japan
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)30813-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-373
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [31] Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa
    Prabdial-Sing, N.
    Blackard, J. T.
    Puren, A. J.
    Mahomed, A.
    Abuelhassan, W.
    Mahlangu, J.
    Vermeulen, M.
    Bowyer, S. M.
    ANTIVIRAL RESEARCH, 2016, 127 : 90 - 98
  • [32] Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells
    Siavoshian, S
    Abraham, JD
    Thumann, C
    Kieny, MP
    Schuster, C
    JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (03) : 402 - 411
  • [33] Significance of NS5B Substitutions in Genotype 1b Hepatitis C Virus Evaluated by Bioinformatics Analysis
    Uchida, Yoshihito
    Nakamura, Shugo
    Kouyama, Jun-Ichi
    Naiki, Kayoko
    Motoya, Daisuke
    Sugawara, Kayoko
    Inao, Mie
    Imai, Yukinori
    Nakayama, Nobuaki
    Tomiya, Tomoaki
    Hedskog, Charlotte
    Brainard, Diana
    Mo, Hongmei
    Mochida, Satoshi
    SCIENTIFIC REPORTS, 2018, 8
  • [34] Significance of NS5B Substitutions in Genotype 1b Hepatitis C Virus Evaluated by Bioinformatics Analysis
    Yoshihito Uchida
    Shugo Nakamura
    Jun-Ichi Kouyama
    Kayoko Naiki
    Daisuke Motoya
    Kayoko Sugawara
    Mie Inao
    Yukinori Imai
    Nobuaki Nakayama
    Tomoaki Tomiya
    Charlotte Hedskog
    Diana Brainard
    Hongmei Mo
    Satoshi Mochida
    Scientific Reports, 8
  • [35] Development and implementation of a novel method for detecting hepatitis C virus resistance-associated substitutions to NS3, NS5A, and NS5B inhibitors in Linzhou, China
    Zhang, Cui
    Nie, Yugang
    Li, Jian
    Ji, Xiaoyu
    Han, Mengjie
    Qin, Rong
    Liu, Yuqiu
    Xing, Wenge
    Qiu, Maofeng
    Li, Ning
    Liu, Zhongfu
    JOURNAL OF VIROLOGICAL METHODS, 2025, 333
  • [36] Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1–4 in Italy
    Ada Bertoli
    Maria Chiara Sorbo
    Marianna Aragri
    Ilaria Lenci
    Elisabetta Teti
    Ennio Polilli
    Velia Chiara Di Maio
    Laura Gianserra
    Elisa Biliotti
    Chiara Masetti
    Carlo F. Magni
    Sergio Babudieri
    Laura A. Nicolini
    Martina Milana
    Pierluigi Cacciatore
    Loredana Sarmati
    Adriano Pellicelli
    Stefania Paolucci
    Antonio Craxì
    Filomena Morisco
    Valeria Pace Palitti
    Massimo Siciliano
    Nicola Coppola
    Nerio Iapadre
    Massimo Puoti
    Giuliano Rizzardini
    Gloria Taliani
    Caterina Pasquazzi
    Massimo Andreoni
    Giustino Parruti
    Mario Angelico
    Carlo Federico Perno
    Valeria Cento
    Francesca Ceccherini-Silberstein
    Scientific Reports, 8
  • [37] A retrospective study of the efficacy of sofosbuvir plus NS5A inhibitors for patients with hepatitis C virus genotype-2 chronic infection
    Lv, Duo-Duo
    Wang, Meng-Lan
    Chen, En-Qiang
    Wu, Dong-Bo
    Tao, Ya-Chao
    Zhang, Dong-Mei
    Tang, Hong
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (03) : 382 - 388
  • [38] Pharmacokinetic Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir in Rats
    Xu, Beibei
    Lin, Xizhou
    Ye, Yi
    Zheng, Liang
    LATIN AMERICAN JOURNAL OF PHARMACY, 2016, 35 (07): : 1567 - 1572
  • [39] Comprehensive Screening for Naturally Occurring Hepatitis C Virus Resistance to Direct-Acting Antivirals in the NS3, NS5A, and NS5B Genes in Worldwide Isolates of Viral Genotypes 1 to 6
    Angel Patino-Galindo, Juan
    Salvatierra, Karina
    Gonzalez-Candelas, Fernando
    Xavier Lopez-Labrador, F.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (04) : 2402 - 2416
  • [40] Impact of Preexisting Hepatitis C Virus Genotype 6 NS3, NS5A, and NS5B Polymorphisms on the In Vitro Potency of Direct-Acting Antiviral Agents
    McPhee, Fiona
    Ueland, Joseph
    Vellucci, Vincent
    Bowden, Scott
    Sievert, William
    Zhou, Nannan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
12345